drugset / Trial / NCT02011269

TSO for Plaque Psoriasis

NCT02011269 ↗

Phase 2 Withdrawn Coronado Biosciences, Inc.
RandomizedParallel-groupDouble-blindTreatment

Summary

This is a randomized, blinded, multicenter study to assess the safety and treatment effect of 12 weeks of Trichuris suis ova in subjects diagnosed with moderate to severe chronic plaque psoriasis.

Timeline

Start
2014-03
Primary completion
2015-01
Completion
—

Outcome

Outcome not reported

Stopped: “Study not conducted”

Drugs

EvaluationDrugModalityDoseRoute
Comparator Trichuris suis ova Other / unclassified 7500 unknown Oral
Comparator Trichuris suis ova Other / unclassified 15000 unknown Oral

Indications